It has been proposed that CD138 (syndecan-1) promotes the survival of mature PCs [69], as well as multiple myeloma cells, by binding of anti-apoptotic factors, growth factors, and pro-survival cytokines, such as APRIL, or IL-6 through its heparan sulfate moieties [70,71]. The gene discussed is IL6; the disease is plasma cell myeloma.